Bitte wählen Sie:

Universitätsklinikum Essen
Direkteinstieg:
Forschung & Lehre

Arbeitsgruppe

Klinische und experimentelle Transplantationshepatologie

Prof. Dr. med. Kerstin Herzer

Medizinisches Forschungszentrum,
Gastro MFZ, 2. OG


Forschungsprojekte

Hepatocellular carcinoma is one of the most often causes of death amongst cancer diseases worldwide. Molecular pathogenetic mechanisms of this complex tumor are so far only insufficiently understood and remain to be clarified in order to establish better therapeutic options which are still extremely limited.

Our interest focuses on
clarifying the role of TRAIL regulation for HCC development
the influence of cytokines in tumor development
the regulatory influence of nuclear body proteins on HCC initiation and development
mechanisms of malignant transformation of hepatocytes in HCV infection

After organ transplantation, immunosuppression displays a special setting for recurrence and development of certain diseases. The influence of immunosuppressive substances on immune functions with focus on the recurrence of HCV infection and HCC are of particular interest of ongoing clinical and molecular research projects.


Mitarbeiter/innen

AG Herzer

Dr. rer. nat. Alexandra Frey

M.Sc. Chemische Biologie, AG Herzer

AG Herzer

Dr. rer. nat. Katja Straub

M.Sc. Chemische Biologie, AG Herzer

AG Herzer

Natalie Vogel

M.Sc. Stem Cells and Regenerative Medicine, AG Herzer


Assoziierte Mitarbeiter/innen

Assoziierte Fachärztin

Dr. med. Peri Husen

Fachärztin für Viszeralchirurgie, Allgemein-, Viszeral- und Transplantationschirurgie

Prof. Dr. med. Kerstin Herzer
AG Leitung

Prof. Dr. med. Kerstin Herzer

Chefärztin der Knappschafts-Klinik Bad Neuenahr, Leitung AG Klinische u. experimentelle Transplantationshepatologie

+49 (0)2641 86-515 E-Mail schreiben Zum Steckbrief